期刊文献+

Caveolin-1促进乳癌Hs578T耐药细胞株侵袭和转移 被引量:4

Promotion of Invasion and Metastasis in Human Breast Carcinoma Hs578T/Dox by Caveolin-1
下载PDF
导出
摘要 通过基因转染技术培育caveolin-1过表达乳癌HS578T耐药细胞株Hs578T/Dox+cav-1和空载体细胞株Hs578T/Dox+vector,探讨caveolin-1蛋白对耐药肿瘤细胞体内和体外侵袭转移能力的影响.由于caveolin-1表达的增加,Hs578T/Dox+cav-1细胞形态变为长梭形,伪足更长而伸展,其粘附能力高于空载体Hs578T/Dox+vector细胞株((0.897±0.163)vs(0.633±0.053),P<0.01).侵袭小室试验发现,Hs578T/Dox+cav-1侵袭转移能力增强,培养6h迁徙进入微孔膜的细胞数比Hs578T/Dox+vector细胞株明显增多((107.8±10.9)vs(80.8±8.07),P<0.01),侵袭破坏matrigel基质蛋白胶进入膜内的细胞数也明显增多((68.8±9.88)vs(25.6±5.41),P<0.01).悬浮培养的Hs578T/Dox+cav-1细胞比Hs578T/Dox+vector细胞更容易聚集,形成相对较致密的细胞团块,24h检测流式细胞凋亡指数下降((8.79±1.54)%vs(16.42±1.42)%,P<0.01).这表明其具有更强的抗失巢凋亡和继续生存的能力,为循环转移的肿瘤细胞定植前取了更多时间.Hs578T/Dox+vector细胞在裸鼠皮下种植成瘤试验中不能成瘤,而Hs578T/Dox+cav-1细胞接种15只裸鼠,全部形成肿瘤,平均直径(0.8±0.45)cm.发现一只成瘤裸鼠双肺可见瘤样肿块转移.HE病理组织染色见肿瘤细胞弥漫性分布,细胞核异型性明显.上述结果表明,caveolin-1对Hs578T耐药肿瘤细胞侵袭、转移和成瘤性具有明显的促进作用. To investigate the effect of caveolin-1 on invasion and metastasis of human breast carcinoma Hs578T doxorubicin-resistanted cells, Hs578T/Dox+cav-1 was as experiment group which up-regulated caveolin-1 by introducing the pCI-neo caveolin-1 gene, and Hs578T/Dox +vector introduced the pCI-neo vector was as controlled group. It was revealed that caveolin-1 in Hs578T/Dox cells is an important factor for mediating filopodia formation, which may enhance the invasive of cells. Hs578T/Dox+cav-1 cell formed long and abundant pseudopodia and only few filopodia were detectable in Hs578T/Dox +vector cells. It was shown that adhesive capability of Hs578T/Dox cells enhanced with up-regulated expression of caveolin-1 protein(P〈0.01). Introducing the caveolin-1 gene into Hs578T/Dox cells enhanced their migration and invasive capability, as revealed by an in vitro chamber invasion assay(P〈0.01). Apoptosis index of Hs578T/Dox+cav-1 group resulting from loss of cell-matrix interactions decreased comparing Hs578T/Dox+vector group(P〈0.01). Caveolin-1 inhibited anoikis of Hs578T/Dox cells and that allowed survival of cancer cells during systemic circulation, thereby facilitating secondary tumor formation in distant organs. The efficacy in vivo of caveolin-1 was tested using cells xenografted into nude mice. Each mouse in both fifteen-mice groups were hypodermically injected with equivalent doses of 5 ×10^5 cells from Hs578T/Dox +cav-1 or Hs578T/Dox +vector. Tumors in Hs578T/Dox +cav-1 group were all formed after injection followed for 4 weeks, while no one in Hs578T/Dox+vector group. Lung metastasis was found in one mouse injected Hs578T/Dox+cav-1 cells. In conclusion, up-regulated caveolin-1 level in Hs578T doxorubicin-resistanted cells markedly elevates their capacity to tumor invasion and metastasis.
出处 《生物化学与生物物理进展》 SCIE CAS CSCD 北大核心 2007年第1期25-30,共6页 Progress In Biochemistry and Biophysics
基金 国家自然科学基金资助项目(30230120).~~
关键词 CAVEOLIN-1 乳癌Hs578T细胞 侵袭 转移 caveolin-1, breast carcinoma Hs578T cells, invasion, metastasis
  • 相关文献

参考文献21

  • 1Hurlstone A F, Reid G, Reeves J R, et al. Analysis of the caveolin-1 gene at human chromosome 7q31.1 in primary tumours and tumour-derived cell lines. Oncogene, 1999, 18 (10): 1881 - 1890.
  • 2Ravid D, Maor S, Werner H, et al. Caveolin-1 inhibits anoikis and promotes survival signaling in cancer cells. Advan Enzyme Regul,2006, 46 (1): 163- 175.
  • 3Liscovitch M, Burgermeister E, Jain N, et al. Caveolin and cancer: a complex relationship. In: Mattson M P, ed. Membrane Microdomain Signaling Lipid Rafts in Biology and Medicine. Totowa, NJ:Humana Press, 2005. 161 - 190.
  • 4Cai C X, Chen J W. Overexpression of caveolin-1 induces alteration of multidrug resistance in Hs578T breast adenocarcinoma cells. Int J Cancer. 2004, 111 (4): 522-529.
  • 5Zhu H, Cai C X, Chen J W. Suppression of P-glycoprotein gene expression in Hs578T/Dox by the overexpression of caveolin-1.FEBS Letters, 2004, 576 (3): 369-374.
  • 6Albini A, Iwamoto Y, Kleinman H K, et al. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res, 1987,47 (12): 3239-3245.
  • 7Frisch S M, Francis H. Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol, 1994, 124 (4): 619-626.
  • 8Frisch S M, Screaton R A. Anoikis mechanisms. Curt Opin Cell Biol, 2001, 13 (5): 555-562.
  • 9Rak J, Mitsuhashi Y, Erdos V, et al. Massive programmed cell death in intestinal epithelial cells induced by three-dimensional growth conditions: suppression by expression of a mutant c-H-ras oncogene.J Cell Biol, 1995, 131 (6 Pt 1): 1587- 1598.
  • 10Zhu Z, Sanchez-Sweatman O, Huang X, et ol. Anoikis and metastatic potential of cloudman S91 melanoma cells. Cancer Res, 2001, 61(4): 1707-1716.

同被引文献42

  • 1谢晓艳,刘澎,李建勇.窖蛋白-1与肿瘤[J].国际病理科学与临床杂志,2006,26(5):372-375. 被引量:5
  • 2沈在雄,曹林升.Caveolin-1与泌尿系肿瘤研究进展[J].国际泌尿系统杂志,2006,26(6):806-809. 被引量:3
  • 3Anderson RG. The caveolae membrane system [J]. Annu Rev Biochem, 1998,67(7) : 199-225.
  • 4Hurlstone AF, Reid G, Reeves JR, et al. Analysis of the caveolin-1 gene at human chromosome 7q31.1 in primary tumours and tumour-derived cell lines [J]. Oncogene, 1999, 18(10) : 1881-1890.
  • 5Liscovitch M, Burgermeister E, Jain N, et al. Caveolin and cancer: a complex relationship [M]. Mattson MP, ed.Membrane microdomain signaling lipid rafts in biology and medicine. Totowa, NJ: Humana Press, 2005: 161-190.
  • 6Cai CX, Chen JW. Overexpression of caveolin-1 induces alteration of multidrug resistance in Hs578T breast adenocarcinoma cells [J]. Int Cancer, 2004,111 (4) :522- 529.
  • 7Zhu H, Cai CX, Chen JW. Suppression of P-glycoprotein gene expression in Hs578T/Doxox by the overexpression of caveolin-1 [J]. FEBS Letters, 2004,576(3):369-374.
  • 8Wu P, Qi BJ, Zhu H, et al. Suppression of staurosporine- mediated apoptosis in Hs578T breast cells through inhibition of neutral-sphingomyelinase by caveolin-1 [J]. Cancer Lett, 2007,256( 1 ) :64-72.
  • 9Yang G, Truong LD, Timme TL, et al. Elevated expression of caveolin is association with prostate and beast cancer [J]. Clin Cancer Res, 1998,4(8) : 1873-1880.
  • 10Cardone MH, Roy N, Stennicke HR, et al. Regulation of cell death protease caspase-9 by phosphorylation [J]. Science, 1998,282(5392) : 1318-1321.

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部